ORANGE GROVE BIO
Orange Grove Bio (“OGB”) is a preclinical drug investment and development platform focused on driving down the cost of drug discovery and advancing therapies into clinical trials.
ORANGE GROVE BIO
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business GStatic Google Static Content Sectigo SSL Sectigo Domain SSL Wix
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-05 | IpiNovyx Bio | Orange Grove Bio investment in Seed Round - IpiNovyx Bio | 10 M USD |
More informations about "Orange Grove Bio"
Meet Our People – Orange Grove Bio
As CEO of Orange Grove Bio, Ryan is dedicated to advancing transformative therapies for cancer, autoimmune, and inflammatory diseases. Leading a team of venture partners with …See details»
Our Mission – Orange Grove Bio
Orange Grove Bio is committed to accelerating the development of innovative, patient-centric therapies for cancer, autoimmune, and inflammatory diseases. We believe in cultivating a collaborative ecosystem that connects early-stage …See details»
Orange Grove Bio - Crunchbase Investor Profile & Investments
Orange Grove Bio (“OGB”) is a preclinical drug investment and development platform focused on driving down the cost of drug discovery and advancing therapies into clinical trials. ... 9,864 …See details»
Orange Grove Bio - Funding, Financials, Valuation & Investors
Orange Grove Bio (“OGB”) is a preclinical drug investment and development platform. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... How …See details»
Orange Grove Bio investment portfolio - PitchBook
Orange Grove Bio's latest investment was on 05-Oct-2021 in IpiNovyx, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most …See details»
Orange Grove Bio — Catalytic Impact Foundation
Orange Grove Bio (“OGB”) is a preclinical drug investment and development platform focused on driving down the cost of drug discovery and advancing therapies into clinical trials. They are …See details»
Orange Grove Bio Provides Corporate Update Highlighting Key …
CINCINNATI, June 23, 2022 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, today announced several key leadership appointments …See details»
Meet our Advisors - Orange Grove Bio
Rob Sarisky is a Senior Advisor to Orange Grove Bio and current President of Health and Life Science Advisors, a boutique firm providing corporate and business development support to life science companies. As an …See details»
Orange Grove Bio Provides Corporate Update Highlighting Key
Jun 23, 2022 Orange Grove Bio Diane Yu, Chief of Staff (814) 689-9730. Taylor Negrete, Executive Assistant to CEO [email protected]. Vida Strategic Partners (on behalf of …See details»
Orange Grove Bio - Investments, Portfolio & Company Exits
Oct 5, 2021 Orange Grove Bio has invested in IpiNovyx Bio on Oct 5, 2021. This investment - Seed Round - IpiNovyx Bio - was valued at . obfuscated. obfuscated. How many investments …See details»
Orange Grove Bio Overview | SignalHire Company Profile
Organization Website: orangegrovebio.com : Orange Grove Bio industries Biotech: Headquarters Location: Cincinnati, Ohio, 45206 US Cincinnati, Ohio, 45206 US : Orange Grove Bio …See details»
Orange Grove Bio Selects Cincinnati Innovation District® for …
CINCINNATI, Nov. 3, 2021 /PRNewswire/ -- Orange Grove Bio, a New York-based preclinical drug investment and development firm, and the University of Cincinnati (UC), a Carnegie Level …See details»
In The Press – Orange Grove Bio
Nov 10, 2023 Get the latest updates from Orange Grove Bio, a leader in the field of biotechnology. From partnerships with top research universities to new developments in …See details»
Orange Grove Bio - Contacts, Employees, Board Members
Orange Grove Bio has 2 current employee profiles, including Chief Executive Officer Marc Appel. Marc Appel Chief Executive Officer Ryan Fox Chief Business Operations OfficerSee details»
Orange Grove Bio Sets Sights on Rapidly Emerging Middle
Jan 31, 2024 Contacts: Orange Grove Bio Taylor Negrete (513) 448-2499 Vida Strategic Partners (on behalf of Orange Grove Bio) Tim Brons (Media) (415) 674-7402 Contact closeSee details»
Internship Hub - Orange Grove Bio
After successfully finishing the Orange Grove Bio Internship program, become a part of our Alumni Network. Stay informed with the latest updates, events, job opportunities, and connect …See details»
Orange Grove Bio Provides Corporate Update Highlighting Key
Jun 23, 2022 Contact Data Vida Strategic Partners (on behalf of Orange Grove Bio) Tim Brons (415) 674-7402See details»
Ohio's Top 25 Innovative Biotechnology Enterprises - Inven
Orange Grove Bio is a preclinical drug investment and development firm focused on accelerating drug development for cancer, autoimmune, and inflammatory diseases. ... Medpace is a full …See details»
Portfolio - Orange Grove Bio
Privacy Policy; Terms & Conditions; FCOI POLICY © 2023 Orange Grove Bio LLC, All Rights ReservedSee details»